Antofagasta plc (LON:ANTO – Get Free Report) has been given a consensus recommendation of “Hold” by the seven ratings firms that are currently covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company. The average 12 month price target among analysts that have covered the stock in the last year is GBX 1,948.57 ($24.56).
Several equities research analysts have recently weighed in on ANTO shares. Deutsche Bank Aktiengesellschaft dropped their target price on shares of Antofagasta from GBX 2,100 ($26.47) to GBX 2,000 ($25.20) and set a “hold” rating for the company in a research report on Monday, September 9th. JPMorgan Chase & Co. dropped their target price on shares of Antofagasta from GBX 1,730 ($21.80) to GBX 1,720 ($21.68) and set an “underweight” rating for the company in a research report on Wednesday, September 11th.
View Our Latest Stock Report on ANTO
Antofagasta Stock Performance
Antofagasta Cuts Dividend
The firm also recently disclosed a dividend, which was paid on Monday, September 30th. Investors of record on Thursday, September 5th were given a dividend of $0.08 per share. This represents a dividend yield of 0.32%. The ex-dividend date was Thursday, September 5th. Antofagasta’s dividend payout ratio is presently 4,406.78%.
About Antofagasta
Antofagasta plc operates as a mining company. It operates through Los Pelambres, Centinela, Antucoya, Zaldívar, Exploration and Evaluation, and Transport Division segments. Its mines produce copper cathodes and copper concentrates; and molybdenum, gold, and silver by-products. The company also has exploration projects in various countries.
Read More
- Five stocks we like better than Antofagasta
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Where Do I Find 52-Week Highs and Lows?
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Roth IRA Calculator: Calculate Your Potential Returns
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Antofagasta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Antofagasta and related companies with MarketBeat.com's FREE daily email newsletter.